Tech Company Financing Transactions

Autolus Funding Round

Arix Bioscience, Cormorant Asset Management and Nextech Invest participated in a $80 million Series C capital raise for Autolus. The funding round closed on 9/28/2017.

Transaction Overview

Company Name
Announced On
9/28/2017
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series C
Proceeds Purpose
The funds raised will enable Autolus to establish clinical proof of concept for three novel haematological cancer programmes: AUTO2 in multiple myeloma, which recently completed the first-dose cohort of its Phase I/II study; AUTO3 which has initiated Phase I/II studies in diffuse large B cell lymphoma and paediatric acute lymphoblastic leukaemia; and AUTO4 in T-cell lymphoma which is ready for the clinic.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
191 Wood Ln. The Mediaworks White City
London, W12 7FP
UK
Email Address
Overview
Autolus is at the forefront of a revolution in cancer treatment. Chimeric Antigen Receptor (CAR) T-cell therapies have been shown to be effective in some haematological malignancies and may have wide applications as a cancer treatment, with the potential to offer a cure.
Profile
Autolus LinkedIn Company Profile
Social Media
Autolus Company Twitter Account
Company News
Autolus News
Facebook
Autolus on Facebook
YouTube
Autolus on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christian Itin
  Christian Itin LinkedIn Profile  Christian Itin Twitter Account  Christian Itin News  Christian Itin on Facebook
Chief Medical Officer
Vijay Reddy
  Vijay Reddy LinkedIn Profile  Vijay Reddy Twitter Account  Vijay Reddy News  Vijay Reddy on Facebook
Chief Operating Officer
Christopher Vann
  Christopher Vann LinkedIn Profile  Christopher Vann Twitter Account  Christopher Vann News  Christopher Vann on Facebook
Chief Scientific Officer
Martin Pule
  Martin Pule LinkedIn Profile  Martin Pule Twitter Account  Martin Pule News  Martin Pule on Facebook
Vice President
Muhammad Al-Hajj
  Muhammad Al-Hajj LinkedIn Profile  Muhammad Al-Hajj Twitter Account  Muhammad Al-Hajj News  Muhammad Al-Hajj on Facebook
VP - General Counsel
Matthias Alder
  Matthias Alder LinkedIn Profile  Matthias Alder Twitter Account  Matthias Alder News  Matthias Alder on Facebook
VP - Manufacturing
James Faulkner
  James Faulkner LinkedIn Profile  James Faulkner Twitter Account  James Faulkner News  James Faulkner on Facebook
VP - Operations
Neil Bell
  Neil Bell LinkedIn Profile  Neil Bell Twitter Account  Neil Bell News  Neil Bell on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/28/2017: Royole venture capital transaction
Next: 9/28/2017: Iris Plans venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary